期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
框架结构大学实验楼后浇带施工方法
1
作者 尚鹏飞 刘平相 +2 位作者 唐强 李福旭 金万浩 《工程设计与施工》 2023年第12期115-118,共4页
论文结合哈尔滨市哈尔滨工业大学教学综合实验楼(西区)项目施工总承包工程施工实际经验,对本工程后浇带施工采用现浇构造柱作为框架结构代替后浇带支模架的关键技术进行分析、总结,并结合其他类型工程提出有效措施。此方法代替通常施工... 论文结合哈尔滨市哈尔滨工业大学教学综合实验楼(西区)项目施工总承包工程施工实际经验,对本工程后浇带施工采用现浇构造柱作为框架结构代替后浇带支模架的关键技术进行分析、总结,并结合其他类型工程提出有效措施。此方法代替通常施工方案中的独立设置的模板支撑架体,增加的混凝土构造柱与同层同轴线主体结构混凝土浇筑同时施工,带构造柱模板、正式主体结构模板拆除后通过构造柱作为独立支撑体系,能够减少传统后浇带独立支撑体系模板架体的租赁费用,拆模后效果美观、占用空间小,可为类似工程提供借鉴和参考,具有一定的推广应用价值。 展开更多
关键词 框架结构 教学综合实验楼 后浇带
下载PDF
Combination therapy with miR34a and doxorubicin synergistically inhibits Doxresistant breast cancer progression via downregulation of Snail through suppressing Notch/NF-kB and RAS/RAF/MEK/ERK signaling pathway 被引量:9
2
作者 Xiaoxia Yang pengfei shang +5 位作者 Bingfang Yu Qiuyang Jin Jing Liao Lei Wang Jianbo Ji Xiuli Guo 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第9期2819-2834,共16页
Resistance to breast cancer(BCa) chemotherapy severely hampers the patient’s prognosis.MicroRNAs provide a potential therapeutic prospect for BCa.In this study,the reversal function of microRNA34 a(miR34 a) on doxoru... Resistance to breast cancer(BCa) chemotherapy severely hampers the patient’s prognosis.MicroRNAs provide a potential therapeutic prospect for BCa.In this study,the reversal function of microRNA34 a(miR34 a) on doxorubicin(Dox) resistance of BCa and the possible mechanism was investigated.We found that the relative level of miR34 a was significantly decreased in Dox-resistant breast cancer cell MCF-7(MCF-7/A) compared with Dox-sensitive MCF-7 cells.Transfection with miR34 a significantly suppressed the invasion,migration,adhesion of MCF-7/A cells without inhibiting their growth obviously.The combination of miR34 a and Dox could significantly inhibit the proliferation,migration,invasion and induce the apoptosis of MCF-7/A cells.The synergistic effect of this combination on resistant MCF-7/A cells has no obvious relation with the expressions of classical drug-resistant proteins P-GP,MRP and GST-π,while closely related with the down-regulation on TOP2 A and BCRP.Moreover,we found both protein and mRNA expression of Snail were significantly up-regulated in MCF-7/A cells in comparison with MCF-7 cells.Transfection with small interfering RNA(siRNA) of Snail could inhibit the invasion,migration and adhesion of drug-resistant MCF-7/A cells,while highexpression of Snail could remarkably promote the invasion,migration and adhesion of MCF-7 cells,which might be related with regulation of N-cadherin and E-cadherin.Transfection with miR34 a in MCF-7/A cells induced a decrease of Snail expression.The potential binding sites of miR34 a with 3’UTR of Snail were predicted by miRDB target prediction software,which was confirmed by luciferase reporter gene method.Results showed that the relative activity of luciferase was reduced in MCF-7/A cells after co-transfection of miR34 a and wild type(wt)-Snail,while did not change by co-transfection with miR34 a and 3’ UTR mutant type(mut) Snail.Combination of miR34 a and Dox induced a stronger decrease of Snail in MCF-7/A cells in comparison to miR34 a or Dox treatment alone.What’ more,for the first time,we also found miR34 a combined with Dox could obviously inhibit the expression of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK pathway in MCF-7/A cells.In vivo study indicated that combination of miR34 a and Dox significantly slowed down tumor growth in MCF-7/A nude mouse xenograft model compared with Dox alone,which was manifested by the down-regulation of Snail and pro-apoptosis effect in tumor xenografts.These results together underline the relevance of miR34 a-driven regulation of Snail in drug resistance and co-administration of miR34 a and Dox may produce an effective therapy outcome in the future in clinic. 展开更多
关键词 Breast cancer miR34a DOX Drug resistance SNAIL Notch/NF-kB RAS/RAF/MEK/ERK Therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部